You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Harvard Business School
Johnson and Johnson
AstraZeneca
Medtronic

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MICONAZOLE NITRATE COMBINATION PACK

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Miconazole Nitrate Combination Pack

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00498680 Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Unknown status Rambam Health Care Campus Phase 4 2007-03-01 A prospective, randomized, 3-arm parallel trial on 45 males with ED that were never exposed to PDE5i therapy (naïve patients) will be enrolled.In each group, every patient will receive three treatment regimes (Viagra®50mg & Levitra®10mg, Viagra®100mg, Levitra®20mg), in different sequences of administration in such a manner that eventually each patient will receive all regimes in a double- blinded fasion.Safety will be evaluated at pre- screening by measuring hourly vital signs (blood pressure, heart rate)for 4 consecutive hours after taking half-dose combination. Any decrease in blood pressure of 20 mmhg below baseline will exclude the subject from the study. Effcacy will be evaluated by questionnaires (IIEF, Quality of erection questionnaire, grade of erection scale, Sear, QVS and Sexual Encounter Profiles for each sexual event). Non-parametric statistical analysis of the collected data Comparing the 3 groups will be performed.
NCT00702507 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed GlaxoSmithKline Phase 4 2007-05-01 The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
NCT00702507 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed Stiefel, a GSK Company Phase 4 2007-05-01 The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug.
NCT01731574 DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate Completed International Partnership for Microbicides, Inc. Phase 1 2012-12-01 This trial will investigate the potential drug-drug interaction between dapivirine vaginal Ring-004 and vaginally administered miconazole nitrate, and will evaluate the safety of co-administration of the dapivirine vaginal ring and miconazole nitrate in healthy, HIV-negative women.
NCT02215395 An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Wom Completed Population Council Phase 1 2014-03-01 To evaluate the pharmacokinetics (PK) of EE and NES released from the CVR in the presence of a single dose and multiple doses of antimycotic co-medication (miconazole nitrate suppository or cream).
NCT03359070 Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris Completed Biolab Sanus Farmaceutica Phase 2 2014-01-29 This trial aims to evaluate the efficacy of dapaconazole tosylate 2% cream in the treatment of Tinea cruris compared to the active control miconazole nitrate 2% cream in patients with a single lesion.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Miconazole Nitrate Combination Pack

Condition Name

Condition Name for Miconazole Nitrate Combination Pack
Intervention Trials
Vulvovaginal Candidiasis 1
Tinea Cruris 1
Impotence 1
HIV 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Miconazole Nitrate Combination Pack
Intervention Trials
Erectile Dysfunction 1
Candidiasis, Vulvovaginal 1
Candidiasis 1
Tinea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Miconazole Nitrate Combination Pack

Trials by Country

Trials by Country for Miconazole Nitrate Combination Pack
Location Trials
United States 5
Israel 1
Panama 1
Brazil 1
Ecuador 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Miconazole Nitrate Combination Pack
Location Trials
Texas 1
Georgia 1
Florida 1
California 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Miconazole Nitrate Combination Pack

Clinical Trial Phase

Clinical Trial Phase for Miconazole Nitrate Combination Pack
Clinical Trial Phase Trials
Phase 4 2
Phase 2 2
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Miconazole Nitrate Combination Pack
Clinical Trial Phase Trials
Completed 4
Unknown status 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Miconazole Nitrate Combination Pack

Sponsor Name

Sponsor Name for Miconazole Nitrate Combination Pack
Sponsor Trials
Aesculape CRO Belgium BV 1
Rambam Health Care Campus 1
Galeno Desenvolvimento de Pesquisas Clínicas 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Miconazole Nitrate Combination Pack
Sponsor Trials
Other 4
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Colorcon
Merck
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.